Company / Operating Income per Share
Theravance Biopharma, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.07
FY2025
5-year range
-$4.01 / -$0.07
FY2021-FY2025
Trend
+92.5%
vs FY2024
Sector context
#59 of 201
Health Care
What the data says
At $-0.07, Theravance Biopharma, Inc.'s operating income per share ranks #59 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $-5.22 in FY2020 to $-0.07 in FY2025.
Based on SEC 10-K filings.
-0.07 in FY2025.
Improved from $-0.86 to $-0.07 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#59 of 201 in Health CareTop 29% of 201This company -$0.07 Sector average -$28.56
▼
+99.7% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 92.5% year-over-year.
- Ranks #59 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.07 | +92.5% |
| FY2024 | -$0.98 | -13.6% |
| FY2023 | -$0.86 | +78.5% |
| FY2022 | -$4.00 | +0.2% |
| FY2021 | -$4.01 | +23.2% |
| FY2020 | -$5.22 | -11.7% |
| FY2019 | -$4.67 | -40.8% |
| FY2018 | -$3.32 | +32.6% |
| FY2017 | -$4.92 | -3.6% |
| FY2016 | -$4.75 | +2.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026